Revolutionary AI technology that analyzes EEG patterns to predict Alzheimer's and Parkinson's disease 5+ years earlier, enabling life-changing early intervention.
Neurodegenerative diseases cause irreversible damage long before symptoms appear. Our AI technology identifies these changes during the critical window when intervention is most effective.
Current diagnostic methods rely on symptomatic presentation, meaning patients are diagnosed only after significant brain damage has occurred.
NeuroPulse uses advanced AI to detect microscopic biomarkers in routine EEG scans years before clinical symptoms emerge.
Early detection enables neuroprotective therapies, lifestyle interventions, and clinical trial enrollment during the critical early stages.
Our proprietary deep learning models analyze complex EEG signals to identify subtle patterns invisible to human experts.
We're pioneering breakthrough technology that enables earlier detection of neurodegenerative diseases, giving patients and physicians the critical time window needed for effective intervention.
To detect neurological diseases during the crucial early stages when treatments are most effective, preventing irreversible brain damage and dramatically improving patient outcomes worldwide.
Advanced machine learning algorithms analyze routine EEG patterns to identify microscopic biomarkers invisible to human experts, providing early warnings years before clinical symptoms emerge.
Seamless integration with existing hospital EEG equipment requires no additional hardware while delivering results in under 60 seconds—maintaining the highest standards of diagnostic accuracy.
Our proprietary deep learning platform combines transformer models and convolutional neural networks to analyze complex EEG signals with unprecedented accuracy.
Ensemble of 1D CNNs and transformer architectures specifically adapted for multi-channel EEG signals, trained on 15,000+ longitudinal recordings with 10-year outcome data.
Patent-pending technology that identifies subtle pre-symptomatic patterns distinguishing early neurodegeneration from normal aging processes.
Novel pipeline that normalizes heterogeneous EEG data across different equipment, configurations, and sampling rates while preserving critical diagnostic information.
Cloud-based platform with FHIR-compliant EHR integration, delivering actionable insights to neurologists within their existing clinical workflows.
A comprehensive diagnostic platform built for neurologists, by neuroscientists.
Validated on 2,000+ historical EEG records with 10-year outcome data. Current prospective studies ongoing at UCSF, UCLA, and Mayo Clinic Arizona with IRB approval for expanded trials in Q1 2025.
Works with existing EEG equipment from all major manufacturers. No new hardware required—simply upload EEG files and receive comprehensive analysis in under 60 seconds.
Clear risk scores with interpretable explanations and visual evidence, enabling neurologists to make informed decisions about early intervention strategies and treatment plans.
FDA 510(k) clearance in progress with clear path to approval. HIPAA-compliant cloud infrastructure with enterprise-grade security and data encryption.
Founded by leading researchers in computational neuroscience and biomedical engineering, with deep expertise in AI, medical devices, and clinical translation.
PhD in Computational Neuroscience from UCSF (2023). Published 8 papers in Nature Neuroscience on applying transformer architectures to neurological time-series data. Research assistant at UCSF Memory & Aging Center where he witnessed the devastating impact of late-stage diagnoses.
PhD in Biomedical Engineering from Stanford (2024). Best Paper Award at Medical Imaging with Deep Learning 2023 for groundbreaking multimodal biomarker fusion research. Stanford Center for Biomedical Informatics Research intern with expertise in FDA regulatory pathways.
Be among the first healthcare institutions to pilot our groundbreaking early detection technology. Limited spots available for Q3 2025 launch.
Our early access program offers exclusive advantages for pioneering healthcare institutions committed to advancing patient care.
Fill out the form below and our team will contact you within 48 hours.
Have questions about NeuroPulse? We'd love to hear from you. Our team is here to help.